Journal-based CME is available every month through the study of designated articles within PM&R, the official scientific journal of the American Academy of Physical Medicine and Rehabilitation.
Learning Objectives
After completing this enduring material, the participant should be able to:
- Demonstrate an increase in, or affirm, their knowledge of clinical medicine and research.
- Evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
- When appropriate, implement changes in practice relevant to the content of the article.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or control the content of an educational activity to disclose all financial relationships with any ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosures are made in written form prior to the start of the educational activity, and any potential conflicts of interest that exist are mitigated prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to affect the strategic direction of AAPM&R and/or control content and their disclosed financial relationships are listed below.
No other planners, faculty, or individuals in control of content disclosed any relevant financial relationships. Through the planning process, all relevant financial relationships have been mitigated.
Principal Faculty:
Editor-in-Chief: Janna Friedly, MD: Disclosed no relevant financial relationships.
Article Authors:
Roger De la Cerna-Luna MD: Disclosed no relevant financial relationships.
Gustavo Tapia-Sequeiros MS: Disclosed no relevant financial relationships.
Brenda Caira-Chuquineyra MS: Disclosed no relevant financial relationships.
Alvaro Taype-Rondan MD: Disclosed no relevant financial relationships.
Daniel Fernandez-Guzman MD: Disclosed no relevant financial relationships.
AAPM&R Medical Education Committee
Rachel A. Brakke Holman, MD, Chair: Disclosed no relevant financial relationships.
Sarah M. Eickmeyer, MD: Disclosed no relevant financial relationships.
Chelsea D. Frost, MD, MS: Disclosed no relevant financial relationships.
David J. Haustein, MD, MBA: PM Consulting, Expert Medical Consulting: Ownership or Partnership; Greene County Medical Society Executive Council, Missouri State Medical Foundation Board: Non-remunerative Positions of Influence
Sarah K. Hwang, MD: Disclosed no relevant financial relationships.
Ravi E. Kasi, MD: Disclosed no relevant financial relationships.
Caroline Pupke, DO: Disclosed no relevant financial relationships.
Monica E. Rho, MD: Disclosed no relevant financial relationships.
McCasey R. Smith, MD: Disclosed no relevant financial relationships.
Jennifer A. Soo Hoo, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Justin L. Weppner, DO: Disclosed no relevant financial relationships.
Alexandra G. Wolfe, DO: Disclosed no relevant financial relationships.
FDA Disclosures
Any faculty member for this activity who intends to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved, will verbally disclose the FDA’s classification at the beginning of their presentation or demonstration.